Page last updated: 2024-10-26

diclofenac and Chronic Lung Injury

diclofenac has been researched along with Chronic Lung Injury in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"Hydrogen sulfide (H(2)S) is a naturally occurring gas that has been shown to be a potent vasodilator."1.35Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury. ( Bhatia, M; Moore, PK; Sidhapuriwala, JN; Sparatore, A, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatia, M1
Sidhapuriwala, JN1
Sparatore, A1
Moore, PK1

Other Studies

1 other study available for diclofenac and Chronic Lung Injury

ArticleYear
Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury.
    Shock (Augusta, Ga.), 2008, Volume: 29, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ceruletide; Diclofenac; Disease Models, Animal; Hy

2008